Welcome to LookChem.com Sign In|Join Free

CAS

  • or

31407-27-9

Post Buying Request

31407-27-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

31407-27-9 Usage

Chemical Classification

Quinoline derivative

Functional Groups

Amino group, Chloro group, Phenyl group, Carbonitrile group

Applications

Synthesis of pharmaceuticals and agrochemicals

Biological Activities

Antimicrobial, Antitumor, Antiviral properties

Importance

Potential for development of new drugs

Usage

Building block in organic synthesis for diverse compound production in pharmaceutical and agricultural industries

Check Digit Verification of cas no

The CAS Registry Mumber 31407-27-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,1,4,0 and 7 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 31407-27:
(7*3)+(6*1)+(5*4)+(4*0)+(3*7)+(2*2)+(1*7)=79
79 % 10 = 9
So 31407-27-9 is a valid CAS Registry Number.

31407-27-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-amino-6-chloro-4-phenylquinoline-3-carbonitrile

1.2 Other means of identification

Product number -
Other names 2-amino-3-cyano-4-phenyl-6-chloroquinoline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:31407-27-9 SDS

31407-27-9Relevant articles and documents

SUBSTITUTED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

-

Page/Page column 16, (2010/06/13)

The present invention relates to sodium channel inhibitors of Formula (I): in which R1, R2, R3, R4, R5, X, Y, and Z are as defined herein, and to their use in the treatment of various disease states,

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 31407-27-9